Study of AntibioTx's  ATx201 Dermal Formulation Initiated

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Study of AntibioTx's  ATx201 Dermal Formulation Initiated at Sinclair Research Center

HOERSHOLM, Denmark, Dec. 21, 2015 (GLOBE NEWSWIRE) -- AntibioTx, a privately held pharmaceutical company dedicated to the development of a novel class of antibiotics to treat bacterial infections and related disorders, today announced the initiation of a study to determine the repeat dose tolerability of the Company’s ATx201, a topical treatment for bacterial skin infections.

The study, entitled, “A 28-Day Dermal Toxicity Study of ATx201 Dermal Formulation Following Twice Daily Topical Administration with a 28-Day Recovery in Hanford Miniature Swine” will be conducted by researchers at the In-Life Testing Facility: Sinclair Research Center, LLC. The objective of the study is to evaluate the potential dermal toxicity of ATx201 Dermal Formulation after it has been administered topically twice daily for 28 days, followed by another 28-day recovery period. The study will be conducted on 26 Hanford miniature swine.

“We look forward to be working with Sinclair Research on this study,” said Morten Sommer, Chief Scientific Officer of AntibioTx. “This research will help us to move forward with the development of ATx201, an important treatment for a variety of skin infections and diseases. The initiation of the repeat dose study is an important milestone for the growth of our company. More importantly, it will bring us another step closer to providing the treatment to patients.”

Sinclair Research offers specialty biomedical research services in a large range of species encompassing most categories of applied human and veterinary medicine. Preclinical research services and preclinical studies compose a significant portion of their repertoire. 

ABOUT AntibioTx

AntibioTx is a privately held, biopharmaceutical company dedicated to developing next generation therapies to treat antibiotic resistant bacteria and infectious diseases. Their novel and patent protected class of antibiotics targets three primary indications that represent an initial target market opportunity of more than 10 billion USD. The candidates overcome current resistance problems and significantly delay the onset of de novo resistance. Additional advantages include reduced risk due to safe use for other disease types and opportunities for synthetization to target a broad variety of indications. AntibioTx’s product pipeline includes ATx201 for treatment of bacterial skin infections, ATx202 for treatment of acne, and ATx401 for treatment of C. difficile infections. All programs are currently under preclinical development.

FOR FURTHER INFORMATION Investor and Media Relations The Ruth Group Tram Bui and Lee Roth +1 646-536-7035 / +1 646-536-7012 tbui@theruthgroup.com / lroth@theruthgroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Samuel Oschin Air & Space Center Takes Flight This Fall

Updated Category News Views 116

The Grand Unveiling: November Highlights Look at this: space nerds, dreamers, and just about anybody with a heartbeat and a sense of wonder should circle November 13, 2026, like a kid with a candy store gift card. That's when the California Science Center throws open the doors to the Samuel Oschin Air and Space Center. You might as well slap a 'world's first' sticker on...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 71

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 73

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
AGIBOT's Worken: A New Era in Robot Productivity

Updated Category News Views 31

Measuring Productivity Goes Beyond Manufacturing Robots aren't just assembly-line tools anymore. In Shanghai, AGIBOT dropped a bombshell at their Innovation Day event: the introduction of Worken, a framework that turns the spotlight on robots' real-world task performance over mere numbers on a production line. Breaking Down Worken Worken, a mash-up of 'Work' and 'Token,'...

Continue Reading
xTool X1: Redefining Laser Fabrication for Makers

Updated Category News Views 118

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

Continue Reading
New Insurance Rules Limit Public Input Amid Controversy

Updated Category News Views 20

Insurance Rules Change the Game, Yet Again When the bureaucracy tightens its grip, consumers often pay the price. California's recent twist in insurance regulations does just that, taking a red pen to public involvement and paving the road for insurers to hike rates with less interference. A Peek Behind the Curtain This new maneuver by the Department of Insurance...

Continue Reading
HiTHIUM Powers Up Australia's Energy Storage Future

Updated Category News Views 85

Just imagine, folks, a slice of the energy world reshaping right under our feet in good ol' Australia. That's the buzz HiTHIUM sparked at All Energy Australia as they showcased their fancy ?Power 6.9MWh, 8-hour long-duration battery storage system (BESS). It wasn’t just about the tech superiority but the strategic planting of stakes in the local energy market....

Continue Reading
Infinite Electronics Reveals Cutting-Edge Connectivity at Electronica

Updated Category News Views 143

Infinite Electronics Makes Waves at Electronica 2026 Let’s get down to brass tacks: Infinite Electronics is setting up one heck of a show at the electronica 2026 in Munich from November 10–13. They're not just there to give out free pens—these guys mean business with connectivity products that cover everything from drones to industrial automation. A Showcase of...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 67

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
Montage Partners Maintains its Founder-Friendly Status

Updated Category News Views 96

A Streak That Speaks Volumes Did you catch the latest from Scottsdale? Montage Partners, that people-first private equity outfit, just notched its sixth straight year on Inc.'s Founder-Friendly Investors list. Not something you snag with a casual handshake or flimsy promises—this accolade is about real, boots-on-the-ground partnership. Apparently, 294 firms made the...

Continue Reading

Top 5 Most Recently Viewed Articles

Aker Horizons ASA Completes Major Share Transfer for Merger

Updated Category News Views 217

Aker Horizons ASA Completes Major Share Transfer for Merger In a notable development, Aker Horizons ASA has taken a significant step toward advancing its planned merger with Aker Horizons Holding AS. This merger aims to consolidate resources and streamline operations, fostering a more robust operational model. Transfer of Shares Recently, Aker Capital AS successfully...

Continue Reading
Coppernico Unveils Promising Copper Drill Results at Sombrero

Updated Category News Views 111

Coppernico Reports Early Success in Drill Program Coppernico Metals Inc. is excited to share updates regarding its first drilling initiative at the Sombrero Project in Peru. With the company's commitment to exploring and developing significant copper-gold deposits, recent holes drilled at the site have provided promising initial results. Results from Initial Drilling The...

Continue Reading
Array Digital Infrastructure Thrives in Record-Setting Quarter

Updated Category News Views 205

Array Digital Infrastructure Reports Strong Growth in Third Quarter Array Digital Infrastructure, Inc. (NYSE: AD) has announced remarkable results for the third quarter of 2025, capturing attention with impressive financial performance. The company's operating revenues soared to $47.1 million, reflecting a significant increase from the $25.7 million reported during the...

Continue Reading
Nuveen Multi-Market Income Fund (JMM) Surges to New Heights

Updated Category News Views 45

Nuveen Multi-Market Income Fund (JMM) Hits 52-Week High In a thriving market environment, the Nuveen Multi-Market Income Fund (JMM) achieved a remarkable 52-week high of $6.43. This milestone signifies notable performance over the past year, with an impressive one-year change of 15.01%. Investor confidence in JMM has notably increased, as its income-generating investment...

Continue Reading
Maxeon Solar's Strategic Shift: Emphasizing U.S. Operations

Updated Category News Views 111

Maxeon Solar's New Direction in the U.S. Market Maxeon Solar Technologies (NASDAQ: MAXN), a prominent player in the solar panel industry, has announced a major shift in its operational strategy, directing its focus solely on the U.S. market. This decision is rooted in the company’s recognition of its strong presence and impending capabilities in local manufacturing,...

Continue Reading